Evolutionary Genomics, Inc. (FNAM) Research

Evolutionary Genomics, Inc., including its affiliated businesses, focuses on investigating and identifying beneficial genes found in humans, various animal species, and commercial agricultural crops. The company has developed its exclusive "Adapted Traits Platform," an advanced technological system designed to pinpoint specific genetic markers that can enhance desirable characteristics in plants. These improvements include aspects such as increased crop yield, elevated sugar content, greater biomass production, enhanced drought tolerance, and superior resistance to pests and diseases. Evolutionary Genomics, Inc. caters to a wide array of clients, spanning governmental organizations, non-profit foundations, and commercial enterprises. Founded in 1990, the company's headquarters are located in Castle Rock, Colorado.

Market snapshot

Symbol
FNAM
Price
$0.00
Day change
0.00%
Market cap
$1.3K
P/E ratio
-0.00x
52-week range
0.0002-0.45
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Core One Labs Inc. (CLABF)
  • Doseology Sciences Inc. (DOSEF)
  • Enzon Pharmaceuticals, Inc. (ENZN)
  • HealthLynked Corp. (HLYK)
  • LFTD Partners Inc. (LIFD)
  • RepliCel Life Sciences Inc. (REPCF)
  • Reflect Scientific, Inc. (RSCF)
  • Sigyn Therapeutics, Inc. (SIGY)

Recent insider activity

  • Messier Walter — F-InKind (78571 shares) on 2022-05-23
  • Messier Walter — M-Exempt (100000 shares) on 2022-05-23
  • WARNECKE STEVE B — F-InKind (52381 shares) on 2022-05-23
  • WARNECKE STEVE B — M-Exempt (66667 shares) on 2022-05-23
  • WARNECKE STEVE B — M-Exempt (66667 shares) on 2022-05-23

Open Evolutionary Genomics, Inc. (FNAM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.